Publication:
Cognitive and Behavioral Inhibition Deficits in Parkinson's Disease: The Hayling Test as a Reliable Marker

dc.contributor.authorSiquier, Antónia
dc.contributor.authorAndres, Pilar
dc.date.accessioned2024-09-18T06:42:25Z
dc.date.available2024-09-18T06:42:25Z
dc.date.issued2021-01-15
dc.description.abstractObjective: The present study seeks to provide an overview of executive (inhibition and flexibility) deficits in Parkinson's disease (PD) by combining a cognitive and behavioral approach. Methods: Fifteen PD patients and 15 healthy controls underwent a neuropsychological and behavioral assessment including the Hayling and Trails Tests, the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP-RS), the Behavior Rating Inventory of Executive Function (BRIEF-A), and the Short Form-36 Health Survey (SF-36). The level of awareness of executive functioning was also analyzed. We finally explored how these neuropsychological and clinical outcomes could relate to each other. Results: PD patients performed significantly worse in both neuropsychological tasks designed to evaluate inhibition abilities. They also reported more inhibition difficulties in everyday life and poorer quality of life. Associations between neuropsychological measures and self-reports were found. Moreover, as indicated by the discrepancy score, PD patients were as accurate as their relatives in self-reporting their executive daily difficulties. Conclusion: Inhibition and cognitive flexibility impairments assessed by the neuropsychological tests (Hayling and Trails tests) seem to capture daily life executive problems in PD. Furthermore, our study provides a deeper understanding of PD patients' and their relatives' experience of these executive dysfunctions.en
dc.description.sponsorshipThis study was part of AS's doctoral thesis. AS received support from the Spanish Ministry of Economy and Competitivity in the form of a FPU predoctoral studentship (REF FPU18/00761). PA was supported by the Ministry of Science, Innovation and Universities (REF PSI2016-75484-R), the Spanish State Agency for Research (AEI), and the European Regional Development Fund (FEDER).es_ES
dc.format.page621603es_ES
dc.format.volume12es_ES
dc.identifier.citationSiquier A, Andres P. Cognitive and Behavioral Inhibition Deficits in Parkinson's Disease: The Hayling Test as a Reliable Marker. Front Aging Neurosci. 2021 Jan 15;12:621603.en
dc.identifier.doi10.3389/fnagi.2020.621603
dc.identifier.issn1663-4365
dc.identifier.journalFrontiers in Aging Neurosciencees_ES
dc.identifier.otherhttp://hdl.handle.net/20.500.13003/9664
dc.identifier.pubmedID33519424es_ES
dc.identifier.puiL634003484
dc.identifier.scopus2-s2.0-85100078377
dc.identifier.urihttps://hdl.handle.net/20.500.12105/23200
dc.identifier.wos612648900001
dc.language.isoengen
dc.publisherFrontiers Media
dc.relation.publisherversionhttps://dx.doi.org/10.3389/fnagi.2020.621603en
dc.rights.accessRightsopen accessen
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectParkinson's disease
dc.subjectInhibition
dc.subjectCognitive flexibility
dc.subjectNeuropsychology
dc.subjectImpulsivity
dc.subjectExecutive functioning
dc.subjectHayling test
dc.subjectEcological validity
dc.titleCognitive and Behavioral Inhibition Deficits in Parkinson's Disease: The Hayling Test as a Reliable Markeren
dc.typeresearch articleen
dspace.entity.typePublication
relation.isPublisherOfPublication9f9fa5ea-093b-43d8-bf2c-5bd65d08a802
relation.isPublisherOfPublication.latestForDiscovery9f9fa5ea-093b-43d8-bf2c-5bd65d08a802

Files